Progression of pancreatic branch duct-type intraductal papillary mucinous neoplasms (BD-IPMNs) after surgery for extrapancreatic malignancies

Egyptian Liver Journal

Table 2 Analysis of factors predicting lesion progression

Factors	Univariate analysis			Multivariate analysis
Factors	OR	95% CI	P	OR	95% CI	P
Male	1.00	0.18–5.58	1.00
Age	0.93	0.83–1.04	0.24
Diabetes mellitus	1.08	0.05–7.18	0.95
Multifocal cysts	1.56	0.28–8.72	0.59
CEA value	0.81	0.58–1.2	0.26
CA19-9 value	0.81	0.98–1.05	0.96
Size of MPD	1.00	0.62–1.82	0.88
Size of cyst	0.96	0.89–1.04	0.27
Mural nodule ( +)	0.96		0.49
Surgery for malignancy of other organs	7.53	1.29–44.1	0.0264	8.73	1.14–76.8	0.0379
Surgery for benign lesion of other organs			0.42

CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, MPD main pancreatic duct, OR odds ratio, CI confidence interval